HONG KONG – China-based Hansoh Pharmaceutical Group Co. Ltd. filed for an IPO in Hong Kong late last week, making it the 11th biopharma company to seek a listing on the Hong Kong Stock Exchange (HKEX) since May and following Ascentage Pharma Group International's IPO a week earlier.
